Deep hyperthermia with radiofrequencies in patients with liver metastases from colorectal cancer
- PMID: 10629627
Deep hyperthermia with radiofrequencies in patients with liver metastases from colorectal cancer
Abstract
Patients at advanced stage of colorectal cancer with liver metastases have been treated with deep hyperthermia alone or in combination with chemotherapy (5-FU + FA + MMC). Hyperthermia was achieved by arrangements of capacitive electrodes with a radiofrequency field of 13.56 MHz (RF-DHT). This prospective open single-arm clinical study with 80 patients suffering from liver metastases from colorectal cancer gives some first hints, that deep RF-hyperthermia alone may have a substantial beneficial effect on overall survival time of patients with liver metastases from colorectal cancer. Long lasting no-change, partial and even some complete remissions could be observed. The overall median survival time from progression of metastases or relapse was 24.5 months and survival rates at 1, 2 or 3 years from first diagnosis of metastases or progression were twice as high as expected from patients treated with chemotherapy. The combination of hyperthermia with delayed chemotherapy did not change overall survival time. These encouraging results deserve to be confirmed in randomized clinical studies.
Similar articles
-
Randomised phase 2 trial of SIR-Spheres plus fluorouracil/leucovorin chemotherapy versus fluorouracil/leucovorin chemotherapy alone in advanced colorectal cancer.J Surg Oncol. 2004 Nov 1;88(2):78-85. doi: 10.1002/jso.20141. J Surg Oncol. 2004. PMID: 15499601 Clinical Trial.
-
Repetitive chemoembolization with melphalan plus intra-arterial immuno-chemotherapy within 5-fluorouracil and granulocyte-macrophage colony-stimulating factor (GM-CSF) as effective first- and second-line treatment of disseminated colorectal liver metastases.Hepatogastroenterology. 2003 Nov-Dec;50(54):1919-26. Hepatogastroenterology. 2003. PMID: 14696433
-
Longterm results and prognostic indicators after cryotherapy and hepatic arterial chemotherapy with or without resection for colorectal liver metastases in 224 patients: longterm survival can be achieved in patients with multiple bilateral liver metastases.J Am Coll Surg. 2006 Jan;202(1):100-11. doi: 10.1016/j.jamcollsurg.2005.08.026. Epub 2005 Nov 2. J Am Coll Surg. 2006. PMID: 16377503
-
[Hepatic arterial infusion chemotherapy for liver metastases from colorectal cancer].Gan To Kagaku Ryoho. 2000 Dec;27(14):2193-200. Gan To Kagaku Ryoho. 2000. PMID: 11142162 Review. Japanese.
-
[Multidisciplinary treatment for colorectal liver metastases].Nihon Geka Gakkai Zasshi. 1998 Jul;99(7):430-5. Nihon Geka Gakkai Zasshi. 1998. PMID: 9742523 Review. Japanese.
Cited by
-
Current treatment for liver metastases from colorectal cancer.World J Gastroenterol. 2003 Feb;9(2):193-200. doi: 10.3748/wjg.v9.i2.193. World J Gastroenterol. 2003. PMID: 12532430 Free PMC article. Review.
-
Upregulation of heat shock proteins and the promotion of damage-associated molecular pattern signals in a colorectal cancer model by modulated electrohyperthermia.Cell Stress Chaperones. 2015 Jan;20(1):37-46. doi: 10.1007/s12192-014-0523-6. Epub 2014 Jun 29. Cell Stress Chaperones. 2015. PMID: 24973890 Free PMC article.
-
Radiofrequence ablation of liver cancers.World J Gastroenterol. 2002 Jun;8(3):393-9. doi: 10.3748/wjg.v8.i3.393. World J Gastroenterol. 2002. PMID: 12046057 Free PMC article. Review.
-
Quo Vadis Oncological Hyperthermia (2020)?Front Oncol. 2020 Sep 4;10:1690. doi: 10.3389/fonc.2020.01690. eCollection 2020. Front Oncol. 2020. PMID: 33014841 Free PMC article. Review.
-
Magnetic fluid hyperthermia induced by radiofrequency capacitive field for the treatment of transplanted subcutaneous tumors in rats.Exp Ther Med. 2012 Feb;3(2):279-284. doi: 10.3892/etm.2011.397. Epub 2011 Nov 30. Exp Ther Med. 2012. PMID: 22969882 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical